Hyperion DeFi announced strong financial results for Q4 and full year 2025, with revenue up 64% quarter-over-quarter to $496K and adjusted gross profit rising 87% to $821K, surpassing company guidance. The growth was driven by diversified DeFi business lines, including staking, validator commissions, and new monetization strategies. Despite a net loss due to treasury asset volatility, the company expects adjusted gross profit to quadruple in 2026, highlighting its strategic shift to build on the Hyperliquid blockchain. Hyperion also advanced its Life Sciences segment with a potential Optejet monetization deal expected to close in Q2 2026.
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multi...
